Clinical Trial Update: Evaluation of the Structural Modification Effect of Diacerein (Artrodar®) in Knee Osteoarthritic Patients [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating whether diacerein (Artrodar) has a structural modification effect in knee osteoarthritis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Knee Osteoarthritis

Drugs mentioned

• Artrodar (diacerein)

Snippet

Sponsor: TRB Chemedica | Conditions: Knee Osteoarthritis | Phase 3 | Status: RECRUITING